All News - Latest Health News and Updates | Watchdoq

‘One Big Beautiful Bill’ Would Batter Rural Hospital Finances, Researchers Say

Rural hospitals would take an outsize hit from Republicans’ proposed cuts to Medicaid and other federal health programs.

Read More

RFK Jr. names new vaccine advisers

In today's D.C. Diagnosis newsletter, RFK Jr. names new vaccine adviers, GOP interest in most-favored nation grows, and more.

Read More

STAT+: FDA clears Capsida gene therapy for clinical trials

And other biotech updates brought to you by The Readout.

Read More

Aircraft Crashes Into Med School; CDC Vaccine Officials Purged; Brian Wilson Dies

(MedPage Today) -- Note that some links may require registration or subscription.

Read More

STAT+: Pharmalittle: We’re reading about Trump and drug prices, BioNTech buying Curevac, and more

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still waiting

Read More

The Real-Life Dating Boot Camp That Inspired ‘Love on the Spectrum’

When U.C.L.A. psychologists first proposed teaching adults with autism how to date, funders wouldn’t go near it. Now we are in a new world.

Read More

STAT+: Medicare Advantage’s supplemental benefits will cost taxpayers $86 billion this year, with little transparency

Taxpayers will send an estimated $86 billion to Medicare Advantage insurers this year to pay for supplemental benefits for their members, or 17% of total payments to those plans.

Read More

MedPAC Calls for Higher Medicare Doc Payments Based on Healthcare Inflation Rate

(MedPage Today) -- Medicare physician pay should be increased yearly, with the increase based on the Medicare Economic Index (MEI), a measure of healthcare inflation, the Medicare Payment Advisory Co

Read More

Where abortion providers are practicing post-Dobbs

And more health news stories of the day.

Read More

STAT+: BioNTech to buy CureVac in $1.25 billion deal, saying it will bolster cancer work

BioNTech said Thursday it would buy CureVac, its onetime competitor in the Covid-19 vaccine race, for about $1.25 billion in an all-stock transaction.

Read More
Health News